As people’s bodies change due to GLP-1s, so does their spending across industries including fashion, restaurants, gyms and ...

The high-profile Australian start-up more than doubled its revenue in the year ending June 30, driven by strong demand in the ...

President boasted that drug prices were falling ‘700%’, a mathematical impossibility, as a result of his executive actions ...

Semaglutide, the drug behind the blockbuster weight-loss jabs Ozempic and Wegovy, does not slow cognitive decline in people with early-stage Alzheimer's, according to two large new studies.

Meghan Trainor decided to quit drinking coffee after a psychic told her husband, Daryl Sabara, that her caffeine intake was ...

Interest in therapies that support weight management has grown rapidly as new metabolic medicines reshape treatment choices ...

CHRISTMAS will be very merry for three million fat jab users — as they are likely to get drunk quickly. Doctors have issued a ...

The explosive rise of drugs like Ozempic and Mounjaro is shifting consumption patterns, health outcomes and pushing ...

Research is important to us for many reasons. Sometimes, for example, research results in a new treatment (e.g., Alexander ...

Patients on popular GLP-1 weight-loss and diabetes jabs should be monitored for suicidal behaviour, the TGA says, while ...

The weight loss market has become one of the hottest areas in the pharmaceutical industry. Investors looking to capitalize on ...

Novo Nordisk just announced price cuts for Ozempic and Wegovy, whose list prices as recently as last year were around $1,000 ...